These findings highlight the pivotal role of c-Abl in α-Synucleinopathies and provide insights into shared mechanisms between infection and pesticide exposure, offering potential therapeutic targets for Parkinson’s disease and related pathologies involving α-Synuclein modification. Here, ABL1 is linked to Parkinson disease.